NPI: 1841264868 · WESTLAKE, OH 44145 · General Acute Care Hospital · NPI assigned 02/15/2006
Authorized official SCHILLERO, ANTHONY controls 20+ related entities in our dataset. Read more
| Authorized Official | SCHILLERO, ANTHONY (DIRECTOR, FP&A) |
| NPI Enumeration Date | 02/15/2006 |
Other providers sharing the same authorized official: SCHILLERO, ANTHONY
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 26,535 | $896K |
| 2019 | 20,395 | $714K |
| 2020 | 18,926 | $822K |
| 2021 | 27,174 | $1.16M |
| 2022 | 33,012 | $1.40M |
| 2023 | 140,730 | $4.26M |
| 2024 | 91,975 | $2.51M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 20,388 | 18,861 | $2.54M |
| 99284 | Emergency department visit for the evaluation and management, high severity | 12,546 | 11,327 | $1.76M |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 12,788 | 10,969 | $1.57M |
| 96361 | Intravenous infusion, hydration; each additional hour | 2,920 | 2,169 | $892K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 2,864 | 2,299 | $625K |
| 70450 | Computed tomography, head or brain; without contrast material | 2,637 | 2,122 | $561K |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 2,394 | 2,200 | $289K |
| 71275 | Computed tomographic angiography, chest, with contrast material | 959 | 731 | $220K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 4,041 | 3,572 | $212K |
| 80053 | Comprehensive metabolic panel | 27,179 | 22,661 | $206K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1,561 | 1,153 | $198K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 871 | 495 | $163K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 2,340 | 1,008 | $161K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 770 | 601 | $145K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 1,695 | 817 | $137K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 1,597 | 538 | $129K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 881 | 833 | $109K |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 1,067 | 962 | $108K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 737 | 683 | $97K |
| G0378 | Hospital observation service, per hour | 1,810 | 836 | $90K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | 1,902 | 544 | $82K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 682 | 625 | $80K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 426 | 327 | $77K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 807 | 334 | $71K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 447 | 369 | $68K |
| 92550 | 611 | 602 | $65K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | 456 | 358 | $60K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 267 | 216 | $60K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 26,348 | 21,954 | $55K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 16,699 | 12,889 | $49K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 1,352 | 1,153 | $39K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 3,315 | 2,899 | $34K |
| 84484 | 12,914 | 7,779 | $34K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 1,086 | 473 | $33K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 443 | 378 | $31K |
| 71046 | Radiologic examination, chest; 2 views | 1,729 | 1,497 | $31K |
| 92557 | 612 | 602 | $31K | |
| 62323 | 73 | 69 | $30K | |
| 76642 | 366 | 308 | $26K | |
| 71045 | Radiologic examination, chest; single view | 6,997 | 5,881 | $23K |
| 97161 | 694 | 525 | $22K | |
| 76000 | 391 | 312 | $22K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | 486 | 414 | $20K |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | 176 | 121 | $16K |
| 93971 | 253 | 212 | $16K | |
| 36415 | Collection of venous blood by venipuncture | 15,911 | 11,811 | $15K |
| 86850 | 885 | 712 | $15K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 644 | 328 | $15K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 1,052 | 810 | $14K |
| 93975 | 110 | 85 | $14K | |
| 97165 | 411 | 276 | $13K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 133 | 125 | $13K |
| 80048 | Basic metabolic panel (calcium, ionized) | 2,300 | 1,229 | $12K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 3,231 | 2,943 | $12K |
| 97535 | Self-care/home management training, each 15 minutes | 555 | 244 | $12K |
| 82805 | 559 | 360 | $12K | |
| 74018 | 556 | 460 | $12K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 9,416 | 8,061 | $12K |
| 72125 | Computed tomography, cervical spine; without contrast material | 1,039 | 818 | $11K |
| 82728 | 616 | 528 | $11K | |
| 85027 | 4,328 | 2,491 | $11K | |
| 20610 | 60 | 41 | $10K | |
| 73564 | 512 | 412 | $10K | |
| 76830 | Ultrasound, transvaginal | 371 | 306 | $9K |
| 96367 | 281 | 196 | $9K | |
| 73030 | 521 | 416 | $9K | |
| 73130 | 499 | 423 | $9K | |
| 84443 | Thyroid stimulating hormone (TSH) | 1,279 | 1,071 | $9K |
| 86900 | 915 | 734 | $8K | |
| 73630 | 590 | 505 | $8K | |
| 83540 | 640 | 552 | $7K | |
| 83735 | 4,599 | 2,860 | $6K | |
| 83550 | 638 | 551 | $6K | |
| 73610 | 446 | 398 | $5K | |
| 82947 | 4,386 | 1,591 | $5K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 488 | 416 | $5K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 2,666 | 1,654 | $5K |
| 12001 | 39 | 28 | $5K | |
| 84702 | 3,078 | 2,547 | $5K | |
| 80320 | 327 | 276 | $5K | |
| 72110 | 71 | 60 | $5K | |
| 82607 | 187 | 149 | $4K | |
| 86140 | 699 | 569 | $4K | |
| 96375 | Therapeutic injection; each additional sequential IV push | 5,343 | 4,125 | $4K |
| 96376 | 1,519 | 782 | $4K | |
| 76982 | 117 | 101 | $4K | |
| 80061 | Lipid panel | 356 | 306 | $4K |
| 73110 | 223 | 188 | $4K | |
| 90715 | 273 | 220 | $4K | |
| 72100 | 142 | 129 | $3K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 2,001 | 1,619 | $3K |
| 97116 | 233 | 99 | $3K | |
| 70486 | 97 | 78 | $3K | |
| J1815 | Injection, insulin, per 5 units | 106 | 26 | $3K |
| 72131 | 68 | 54 | $3K | |
| 93970 | 29 | 27 | $3K | |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | 14 | 12 | $3K |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | 15 | 15 | $3K |
| 81003 | 5,447 | 4,830 | $3K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 113 | 111 | $3K |
| 80069 | 495 | 277 | $3K | |
| 82247 | 143 | 122 | $3K | |
| A9270 | Non-covered item or service | 8,648 | 926 | $2K |
| 99152 | 512 | 399 | $2K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 146 | 145 | $2K |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | 167 | 103 | $2K |
| 83690 | 4,176 | 3,462 | $2K | |
| 87081 | 142 | 129 | $2K | |
| 76536 | 13 | 13 | $2K | |
| 76770 | 15 | 14 | $2K | |
| 81001 | 5,249 | 4,418 | $2K | |
| 77062 | 55 | 53 | $2K | |
| 83605 | 2,410 | 1,516 | $2K | |
| 12011 | 13 | 12 | $1K | |
| 99215 | Prolong outpt/office vis | 14 | 12 | $1K |
| 87040 | 1,215 | 528 | $1K | |
| 85610 | 3,891 | 3,223 | $1K | |
| J1170 | Injection, hydromorphone, up to 4 mg | 2,379 | 1,183 | $1K |
| 86901 | 915 | 734 | $1K | |
| 73502 | 92 | 82 | $1K | |
| 83655 | 34 | 33 | $1K | |
| 71250 | 16 | 13 | $1K | |
| 83880 | 1,387 | 1,067 | $1K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 799 | 706 | $1K |
| 93017 | 16 | 12 | $1K | |
| 97162 | 34 | 29 | $1K | |
| 83615 | 166 | 120 | $1K | |
| 73562 | 16 | 13 | $1K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 602 | 323 | $1K |
| J3490 | Unclassified drugs | 1,715 | 808 | $1K |
| 83036 | Hemoglobin; glycosylated (A1C) | 251 | 174 | $970.43 |
| J2543 | Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) | 356 | 148 | $950.63 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 96 | 80 | $880.62 |
| 77065 | Tomosynthesis, mammo | 31 | 25 | $879.24 |
| 99153 | Mod sedat endo service >5yrs | 34 | 26 | $859.72 |
| 80143 | 761 | 572 | $841.81 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 291 | 235 | $807.20 |
| 85379 | 1,202 | 974 | $733.80 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | 1,927 | 1,230 | $712.78 |
| 82077 | 587 | 414 | $700.83 | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 96 | 80 | $669.80 |
| 81025 | 1,791 | 1,445 | $666.54 | |
| 85652 | 310 | 244 | $650.25 | |
| J7030 | Infusion, normal saline solution , 1000 cc | 5,219 | 4,332 | $639.94 |
| 85730 | 707 | 517 | $588.15 | |
| J1650 | Injection, enoxaparin sodium, 10 mg | 967 | 339 | $574.21 |
| 87634 | 488 | 449 | $552.44 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | 3,710 | 2,629 | $546.23 |
| 82533 | 14 | 14 | $523.16 | |
| 94729 | 14 | 13 | $515.98 | |
| 94726 | 12 | 12 | $515.98 | |
| 77066 | Tomosynthesis, mammo | 95 | 83 | $510.44 |
| 84100 | 491 | 309 | $457.70 | |
| 80179 | 745 | 564 | $403.16 | |
| G0404 | Electrocardiogram, routine ecg with 12 leads; tracing only, without interpretation and report, performed as a screening for the initial preventive physical examination | 128 | 76 | $373.13 |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | 1,282 | 310 | $360.91 |
| 73090 | 51 | 43 | $340.68 | |
| 83525 | 14 | 14 | $328.81 | |
| 87077 | 317 | 193 | $320.21 | |
| 73140 | 29 | 26 | $288.24 | |
| 84132 | 545 | 372 | $286.09 | |
| 82378 | 15 | 12 | $274.76 | |
| 82330 | 478 | 291 | $265.30 | |
| 87075 | 548 | 407 | $249.14 | |
| 85007 | 92 | 69 | $237.81 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 3,082 | 2,257 | $233.56 |
| 87205 | 158 | 120 | $222.41 | |
| J0689 | Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg | 1,054 | 650 | $202.29 |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 14 | 14 | $200.38 |
| 87186 | 327 | 224 | $195.92 | |
| C9113 | Injection, pantoprazole sodium, per vial | 120 | 76 | $189.15 |
| J1644 | Injection, heparin sodium, per 1000 units | 876 | 365 | $172.30 |
| 85018 | 499 | 325 | $165.96 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 5,532 | 4,511 | $158.96 |
| 82550 | 341 | 216 | $156.34 | |
| 82248 | 16 | 12 | $124.73 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 5,647 | 4,219 | $115.46 |
| 73080 | 14 | 12 | $112.46 | |
| 82435 | 387 | 256 | $108.69 | |
| J7999 | Compounded drug, not otherwise classified | 397 | 291 | $99.20 |
| 87070 | 64 | 52 | $97.68 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 898 | 550 | $88.10 |
| J2704 | Injection, propofol, 10 mg | 1,941 | 1,372 | $76.30 |
| 87800 | 15 | 13 | $72.96 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 2,364 | 1,600 | $69.06 |
| J1030 | Injection, methylprednisolone acetate, 40 mg | 239 | 211 | $68.04 |
| 84295 | 391 | 257 | $67.04 | |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | 119 | 82 | $65.26 |
| 80329 | 100 | 42 | $64.18 | |
| 73590 | 27 | 25 | $59.57 | |
| J8540 | Dexamethasone, oral, 0.25 mg | 394 | 237 | $59.48 |
| J3475 | Injection, magnesium sulfate, per 500 mg | 413 | 291 | $58.66 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 780 | 575 | $52.88 |
| J2060 | Injection, lorazepam, 2 mg | 156 | 106 | $38.35 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 3,027 | 2,363 | $36.49 |
| J3370 | Injection, vancomycin hcl, 500 mg | 46 | 27 | $36.34 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 1,464 | 1,030 | $35.78 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 550 | 413 | $32.60 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 242 | 208 | $27.28 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 117 | 77 | $26.48 |
| A9575 | Injection, gadoterate meglumine, 0.1 ml | 399 | 324 | $25.54 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 464 | 296 | $24.68 |
| J0690 | Injection, cefazolin sodium, 500 mg | 181 | 122 | $19.92 |
| A4217 | Sterile water/saline, 500 ml | 158 | 117 | $18.26 |
| 94761 | 561 | 431 | $11.66 | |
| J1040 | Injection, methylprednisolone acetate, 80 mg | 178 | 162 | $10.93 |
| J2272 | Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg | 35 | 31 | $10.40 |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 179 | 113 | $10.26 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 32 | 27 | $7.20 |
| J0780 | Injection, prochlorperazine, up to 10 mg | 15 | 13 | $7.00 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | 381 | 259 | $6.31 |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | 314 | 184 | $5.28 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 338 | 295 | $3.74 |
| J7060 | 5% dextrose/water (500 ml = 1 unit) | 95 | 42 | $3.69 |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | 129 | 111 | $3.57 |
| J3480 | Injection, potassium chloride, per 2 meq | 15 | 12 | $3.39 |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | 20 | 14 | $3.31 |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 229 | 198 | $3.29 |
| J1171 | Injection, hydromorphone, 0.1 mg | 105 | 70 | $2.84 |
| J7050 | Infusion, normal saline solution, 250 cc | 101 | 82 | $2.04 |
| J1596 | Injection, glycopyrrolate, 0.1 mg | 64 | 63 | $0.33 |
| 94760 | 344 | 209 | $0.00 | |
| C1769 | Guide wire | 89 | 75 | $0.00 |
| 76377 | 115 | 89 | $0.00 | |
| 87449 | 174 | 96 | $0.00 | |
| 72128 | 18 | 15 | $0.00 | |
| J1010 | Injection, methylprednisolone acetate, 1 mg | 13 | 13 | $0.00 |
| 86308 | 14 | 13 | $0.00 | |
| C1894 | Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser | 58 | 40 | $0.00 |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 126 | 96 | $0.00 |
| 00731 | 56 | 39 | $0.00 | |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 56 | 24 | $0.00 |